Skip to Content
Still using that old version of Internet Explorer? This site will work much better in a newer version of IE or Firefox.
Download Internet Explorer 8 or Firefox 3 now!

parasitology

Francis Ndungu

francis-ndungu.jpg
Email: 
fndunguatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

Immunity to malaria is slow to develop, is non-sterilising and wanes rapidly when immune adults migrate to non-endemic regions, suggesting that specific problems exist in the establishment and main

Margaret Mackinnon

mmackinnon-head.jpg
Email: 
mmackinnonatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

What is it that causes pathogens to harm their host? In my lab, we study the evolutionary pressures, and the biology underlying them, that make pathogens virulent.

Martin Rono

Martin-Rono.jpg
Email: 
mronoatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

Martin Rono has come to join Margaret Mackinnon's team as a post-doctoral research assistant.

Improving the surveillance of paediatric malaria in Kenya & Uganda

Principal Investigator(s): 
Emelda Aluoch Okiro

With the onset of a rapidly changing malaria risk pattern in many parts of Kenya it has become important to establish reliable information on the changes in the epidemiology of disease presenting to health facilities and hospitals. Routine data are inadequate to describe a changing clinical epidemiology, subject as they are to vagaries of incomplete data and poor diagnostics. Prospective hospital and clinic surveillance systems using simplified screening tools, universal parasitological investigations and modern information transfer technology are required. These will be established at various sites across Kenya in collaboration with national research partners between 2010 and 2015.

Antimalarial potential of Methotrexate and aminopterin

Full Title: 
Development of New Drugs for the Treatment of Malaria: The antimalarial potential of Methotrexate and aminopterin
Principal Investigator(s): 
Alexis Nzila

European Union grant from March 2007 to March 2010 on the "Development of New Drugs for the Treatment of Malaria: The antimalarial potential of Methotrexate and aminopterin"

Mechanisms of resistance to the antimalarial drugs lumefantrine, piperaquine and amodiaquine

Full Title: 
Investigation of mechanisms of resistance to the antimalarial drugs lumefantrine, piperaquine and amodiaquine in Africa
Principal Investigator(s): 
Alexis Nzila

Irish Health Research Board (HRB)[GHRA-06-03] of the Republic of Ireland. Project grant from January 2007- December 2009, on "Investigation of mechanisms of resistance to the antimalarial drugs lumefantrine, piperaquine and amodiaquine in Africa", co-investigator with Dr Agnus Bell of Trinity College, Dublin.

Assessing the serological response to recombinant PfEMP1 peptides

Principal Investigator(s): 
Pete Bull

No description available.

Developing mathematical models to describe the population structure of PfEMP1

Principal Investigator(s): 
Pete Bull

No description available.

Molecular studies on the parasite rosetting phenotype

Principal Investigator(s): 
Pete Bull

No description available.